We can't find the internet
Attempting to reconnect
37213.1 IP-LS
37213.1 IP-LS
Résumé
Targeting mTOR Kinase in Cancer and Neurological Disorders
Textes supplémentaires
Abstract
Hyperactivation of mechanistic target of rapamycin (mTOR) induces epilepsy, CNS dysfunction and benign tumors. Treatment options are ineffective and poorly tolerated. A first-in-class, brain-penetrant, selective inhibitor of mTOR kinase with improved tolerability and efficacy will be identified.
Participants
Debora Schmitz
Wirtschaftspartner
Debora.Schmitz@piqur.com
PIQUR Therapeutics AG Debora Schmitz Hochbergerstrasse 60C 4057 Basel BS CH
Matthias Wymann
Kontaktperson
matthias.wymann@unibas.ch
Universität Basel CHE-115.244.907 Matthias Wymann Mattenstrasse 28 4058 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2019-10-31
- Date de fin
- 2021-05-31
- Coûts totaux approuvés
- CHF 910546.88
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%